cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.6413954
title: Realistic soil carbon sequestration considering food security and climate change

description: This dataset contains soil organic carbon stocks as described in Keel et al. Global Change Biology (submitted) Annual soil organic carbon (SOC) stocks (t C ha-1, 0-30 cm depth) of Swiss agricultural soils simulated with the model RothC for the years 2020-2100. Simulations were performed for 240 strata (regions with similar agricultural production types, climatic conditions and clay content). The SOC stocks are weighted averages across strata for the national scale. <br> Each column contains SOC stocks for a specific combination of a climate model chains (nine in total) and an emission scenario (three in total: RCP 26, RCP 45, RCP 85) (specified in column header). The results include simulated SOC stocks for a baseline scenario and five soil carbon sequestration (SCS) scenarios (cover crops, biochar amendment at two rates, biochar amendment based on biomass from two agroforestry scenarios). <br> The SCS scenarios were only performed on cropland, therefore there is only a single file for grassland (the baseline scenario). <br> All simulations (i.e. baseline as well as the five scenarios) account for changes in crop shares and organic matter additions associated with growing food demand as well as climate change. The scenarios are described in Keel et al. Global Change Biology (submitted) CL_baseline: Baseline scenario for cropland (CL) <br> GL_baseline: Baseline scenario for permanent grassland (GL)<br> CL_cover_crops: Cover crop scenario for cropland <br> CL_biochar_I: Biochar I scenario for cropland <br> CL_biochar_II: Biochar II scenario for cropland <br> CL_agroforestry_I: Agroforestry I scenario for cropland <br> CL_agroforestry_II: Agroforestry II scenario for cropland
DOI: 10.6084/m9.figshare.16529476
title: Treatment of difficult-to-treat depression – clinical guideline for selected interventions

description: Difficult-to-treat-depression (DTD) is a clinical challenge. The interventions that are well-established for DTD are not suitable or effective for all the patients. Therefore, more treatment options are highly warranted. We formulated an evidence-based guideline concerning six interventions not well-established for DTD in Denmark. Selected review questions were formulated according to the PICO principle with specific definitions of the patient population (P), the intervention (I), the comparison (C), and the outcomes of interest (O), and systematic literature searches were performed stepwise for each review question to identify relevant systematic reviews/meta-analyses, and randomized controlled trials. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the methodological quality of the included studies. Clinical recommendations were formulated based on the evidence, the risk-benefit ratio, and perceived patient preferences. We found sufficient evidence for a weak recommendation of repetitive transcranial magnetic stimulation (rTMS) and cognitive behavioural analysis system of psychotherapy (CBASP). The use of bright light therapy in DTD was not sufficiently supported by the evidence, but should be considered as good clinical practice. The interventions should be considered in addition to ongoing antidepressant treatment. We did not find sufficient evidence to recommend intravenous ketamine/esketamine, rumination-focused psychotherapy, or cognitive remediation to patients with DTD. The evidence supported two of the six reviewed interventions, however it was generally weak which emphasizes the need for more good quality studies. This guideline does not cover all treatment options and should be regarded as a supplement to relevant DTD-guidelines.
DOI: 10.6084/m9.figshare.16529476.v2
title: Treatment of difficult-to-treat depression – clinical guideline for selected interventions

description: Difficult-to-treat-depression (DTD) is a clinical challenge. The interventions that are well-established for DTD are not suitable or effective for all the patients. Therefore, more treatment options are highly warranted. We formulated an evidence-based guideline concerning six interventions not well-established for DTD in Denmark. Selected review questions were formulated according to the PICO principle with specific definitions of the patient population (P), the intervention (I), the comparison (C), and the outcomes of interest (O), and systematic literature searches were performed stepwise for each review question to identify relevant systematic reviews/meta-analyses, and randomized controlled trials. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the methodological quality of the included studies. Clinical recommendations were formulated based on the evidence, the risk-benefit ratio, and perceived patient preferences. We found sufficient evidence for a weak recommendation of repetitive transcranial magnetic stimulation (rTMS) and cognitive behavioural analysis system of psychotherapy (CBASP). The use of bright light therapy in DTD was not sufficiently supported by the evidence, but should be considered as good clinical practice. The interventions should be considered in addition to ongoing antidepressant treatment. We did not find sufficient evidence to recommend intravenous ketamine/esketamine, rumination-focused psychotherapy, or cognitive remediation to patients with DTD. The evidence supported two of the six reviewed interventions, however it was generally weak which emphasizes the need for more good quality studies. This guideline does not cover all treatment options and should be regarded as a supplement to relevant DTD-guidelines.
DOI: 10.6084/m9.figshare.16529476.v1
title: Treatment of difficult-to-treat depression – clinical guideline for selected interventions

description: Difficult-to-treat-depression (DTD) is a clinical challenge. The interventions that are well-established for DTD are not suitable or effective for all the patients. Therefore, more treatment options are highly warranted. We formulated an evidence-based guideline concerning six interventions not well-established for DTD in Denmark. Selected review questions were formulated according to the PICO principle with specific definitions of the patient population (P), the intervention (I), the comparison (C), and the outcomes of interest (O), and systematic literature searches were performed stepwise for each review question to identify relevant systematic reviews/meta-analyses, and randomized controlled trials. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system was used to assess the methodological quality of the included studies. Clinical recommendations were formulated based on the evidence, the risk-benefit ratio, and perceived patient preferences. We found sufficient evidence for a weak recommendation of repetitive transcranial magnetic stimulation (rTMS) and cognitive behavioural analysis system of psychotherapy (CBASP). The use of bright light therapy in DTD was not sufficiently supported by the evidence, but should be considered as good clinical practice. The interventions should be considered in addition to ongoing antidepressant treatment. We did not find sufficient evidence to recommend intravenous ketamine/esketamine, rumination-focused psychotherapy, or cognitive remediation to patients with DTD. The evidence supported two of the six reviewed interventions, however it was generally weak which emphasizes the need for more good quality studies. This guideline does not cover all treatment options and should be regarded as a supplement to relevant DTD-guidelines.
DOI: 10.5517/ccdc.csd.cc2bg9gl
title: CCDC 2158699: Experimental Crystal Structure Determination

description: Related Article: Hannes Vitze, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9hm
title: CCDC 2158700: Experimental Crystal Structure Determination

description: Related Article: Hannes Vitze, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9jn
title: CCDC 2158701: Experimental Crystal Structure Determination

description: Related Article: Hannes Vitze, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9kp
title: CCDC 2158702: Experimental Crystal Structure Determination

description: Related Article: Hannes Vitze, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9sx
title: CCDC 2158709: Experimental Crystal Structure Determination

description: Related Article: Sebastian Scheuermann, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9lq
title: CCDC 2158703: Experimental Crystal Structure Determination

description: Related Article: Hannes Vitze, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9ty
title: CCDC 2158710: Experimental Crystal Structure Determination

description: Related Article: Sebastian Scheuermann, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9mr
title: CCDC 2158704: Experimental Crystal Structure Determination

description: Related Article: Hannes Vitze, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9vz
title: CCDC 2158711: Experimental Crystal Structure Determination

description: Related Article: Sebastian Scheuermann, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9ns
title: CCDC 2158705: Experimental Crystal Structure Determination

description: Related Article: Hannes Vitze, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9w0
title: CCDC 2158712: Experimental Crystal Structure Determination

description: Related Article: Sebastian Scheuermann, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9x1
title: CCDC 2158713: Experimental Crystal Structure Determination

description: Related Article: Sebastian Scheuermann, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9y2
title: CCDC 2158714: Experimental Crystal Structure Determination

description: Related Article: Sebastian Scheuermann, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bg9z3
title: CCDC 2158715: Experimental Crystal Structure Determination

description: Related Article: Sebastian Scheuermann, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bgb05
title: CCDC 2158716: Experimental Crystal Structure Determination

description: Related Article: Sebastian Scheuermann, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.5517/ccdc.csd.cc2bgb16
title: CCDC 2158717: Experimental Crystal Structure Determination

description: Related Article: Sebastian Scheuermann, Michael Bolte, Matthias Wagner|2022|CSD Communication|||
DOI: 10.6084/m9.figshare.19518772
title: Dose-dependent Ketamine EEG Case Report

description: Resting state EEG experiment during intranasal ketamine treatment in a 22 year old male moderate depression as an adjunct to sertraline 50mg therapy.<br>Closed-eyes EEG was recorded with Muse-S (256Hz sampling rate, 4 channels referenced to Fpz).<br>Dataset contains 2 baseline recordings (immediately before and a few days prior) and 4 recordings during the ketamine administration. An additional Matlab file includes dose and recording timing details and effect-site concentrations calculated using the Leiden and Clements models.<br><br>Dataset contains ~3 minutes eyes-closed resting state EEG before ketamine and 80 minutes after taking ketamine.
DOI: 10.6084/m9.figshare.19518772.v1
title: Dose-dependent Ketamine EEG Case Report

description: Resting state EEG experiment during intranasal ketamine treatment in a 22 year old male moderate depression as an adjunct to sertraline 50mg therapy.<br>Closed-eyes EEG was recorded with Muse-S (256Hz sampling rate, 4 channels referenced to Fpz).<br>Dataset contains 2 baseline recordings (immediately before and a few days prior) and 4 recordings during the ketamine administration. An additional Matlab file includes dose and recording timing details and effect-site concentrations calculated using the Leiden and Clements models.<br><br>Dataset contains ~3 minutes eyes-closed resting state EEG before ketamine and 80 minutes after taking ketamine.
DOI: 10.5281/zenodo.6414033
title: Dataset from Benhamou et al.

description: This upload contains the dataset generated in the study Benhamou et al., and the R script used for the data visualization and analysis.
DOI: 10.5281/zenodo.6352923
title: Dataset from Benhamou et al.

description: This upload contains the dataset generated in the study Benhamou et al., and the R script used for the data visualization and analysis.
DOI: 10.14278/rodare.1498
title: A user-friendly R Platform for Optimizing Mineral Processing

description: An open-source and user-friendly platform for using design of experiments for optimizing mineral processing. No specific knowledge of programming languages is required for using the platform. Depending on the user needs, the platform suggests the optimal experimental strategy with a minimum number of runs required. Different types of experimental designs such as screening, full factorial and central composite designs are currently available. The R shiny app can be accessed via: https://hifgeomet.shinyapps.io/Optimization_Tool/
DOI: 10.14278/rodare.1508
title: A user-friendly R Platform for Optimizing Mineral Processing

description: An open-source and user-friendly platform for using design of experiments for optimizing mineral processing. No specific knowledge of programming languages is required for using the platform. Depending on the user needs, the platform suggests the optimal experimental strategy with a minimum number of runs required. Different types of experimental designs such as screening, full factorial and central composite designs are currently available. The R shiny app can be accessed via: https://hifgeomet.shinyapps.io/Optimization_Tool/
DOI: 10.14278/rodare.1499
title: A user-friendly R Platform for Optimizing Mineral Processing

description: An open-source and user-friendly platform for using design of experiments for optimizing mineral processing. No specific knowledge of programming languages is required for using the platform. Depending on the user needs, the platform suggests the optimal experimental strategy with a minimum number of runs required. Different types of experimental designs such as screening, full factorial and central composite designs are currently available. The R shiny app can be accessed via: https://hifgeomet.shinyapps.io/Optimization_Tool/
DOI: 10.6084/m9.figshare.14381678.v1
title: Audiometric profiles and patterns of benefit: a data-driven analysis of subjective hearing difficulties and handicaps

description: Hearing rehabilitation attempts to compensate for auditory dysfunction, reduce hearing difficulties and minimise participation restrictions that can lead to social isolation. However, there is no systematic approach to assess the quality of the intervention at an individual level that might help to evaluate the need of further hearing rehabilitation in the hearing care clinic. A data-driven analysis on subjective data reflecting hearing disabilities and handicap was chosen to explore “benefit patterns” as a result of rehabilitation in different audiometric groups. The method was based on (1) dimensionality reduction; (2) stratification; (3) archetypal analysis; (4) clustering; (5) item importance estimation. 572 hearing-aid users completed questionnaires of hearing difficulties (speech, spatial and qualities hearing scale; SSQ) and hearing handicap (HHQ). The data-driven approach revealed four benefit profiles that were different for each audiometric group. The groups with low degree of high-frequency hearing loss (HL<sub>HF</sub>) showed a priority for rehabilitating hearing handicaps, whereas the groups with HL<sub>HF</sub> &gt; 50 dB HL showed a priority for improvements in speech understanding. The patterns of benefit and the stratification approach might guide the clinical intervention strategy and improve the efficacy and quality of service in the hearing care clinic.
DOI: 10.6084/m9.figshare.14381678
title: Audiometric profiles and patterns of benefit: a data-driven analysis of subjective hearing difficulties and handicaps

description: Hearing rehabilitation attempts to compensate for auditory dysfunction, reduce hearing difficulties and minimise participation restrictions that can lead to social isolation. However, there is no systematic approach to assess the quality of the intervention at an individual level that might help to evaluate the need of further hearing rehabilitation in the hearing care clinic. A data-driven analysis on subjective data reflecting hearing disabilities and handicap was chosen to explore “benefit patterns” as a result of rehabilitation in different audiometric groups. The method was based on (1) dimensionality reduction; (2) stratification; (3) archetypal analysis; (4) clustering; (5) item importance estimation. 572 hearing-aid users completed questionnaires of hearing difficulties (speech, spatial and qualities hearing scale; SSQ) and hearing handicap (HHQ). The data-driven approach revealed four benefit profiles that were different for each audiometric group. The groups with low degree of high-frequency hearing loss (HL<sub>HF</sub>) showed a priority for rehabilitating hearing handicaps, whereas the groups with HL<sub>HF</sub> &gt; 50 dB HL showed a priority for improvements in speech understanding. The patterns of benefit and the stratification approach might guide the clinical intervention strategy and improve the efficacy and quality of service in the hearing care clinic.
DOI: 10.6084/m9.figshare.19213500
title: Supplementary Material for: Shengxuebao Mixture for Iron Deficiency Anemia: A Meta-Analysis and Systematic Review

description: Objective Traditional Chinese medicine Shengxuebao Mixture (SXBM) has been approved for treating iron deficiency anemia (IDA) in China. This study aimed to collect evidence and quantify the effect of SXBM on IDA. Methods Seven online databases were surveyed up to July 13, 2021. Randomized controlled trials in which SXBM was combined with conventional therapies to treat IDA and compared with placebo or conventional therapies were included in the study. The red blood cell (RBC) count, hemoglobin (Hb) level, and serum ferritin (SF) level, and adverse events rate (AER) were evaluated. Results A total of 1108 patients from 8 trials were recruited. SXBM plus conventional therapy increased the Hb level [mean difference (MD) = 13.04, 95% confidence interval (CI) 8.37–17.7, P &lt; 0.00001], RBC count (MD = 0.41, 95% CI 0.19–0.62, P = 0.002), and SF level (MD = 6.25, 95% CI 2.88–9.62, P = 0.0003),and AER [Risk Ratio(RR)=0.56 ,95% CI 0.36–0.86; P = 0.008]. Conclusions SXBM combined with conventional treatment seemed to be beneficial for patients with IDA. However, the harmlessness of SXBM were not confirmed due to insufficient trials and low methodological quality.Follow-up clinical studies should be cautiously designed, and more research is needed.
DOI: 10.6084/m9.figshare.19213500.v1
title: Supplementary Material for: Shengxuebao Mixture for Iron Deficiency Anemia: A Meta-Analysis and Systematic Review

description: Objective Traditional Chinese medicine Shengxuebao Mixture (SXBM) has been approved for treating iron deficiency anemia (IDA) in China. This study aimed to collect evidence and quantify the effect of SXBM on IDA. Methods Seven online databases were surveyed up to July 13, 2021. Randomized controlled trials in which SXBM was combined with conventional therapies to treat IDA and compared with placebo or conventional therapies were included in the study. The red blood cell (RBC) count, hemoglobin (Hb) level, and serum ferritin (SF) level, and adverse events rate (AER) were evaluated. Results A total of 1108 patients from 8 trials were recruited. SXBM plus conventional therapy increased the Hb level [mean difference (MD) = 13.04, 95% confidence interval (CI) 8.37–17.7, P &lt; 0.00001], RBC count (MD = 0.41, 95% CI 0.19–0.62, P = 0.002), and SF level (MD = 6.25, 95% CI 2.88–9.62, P = 0.0003),and AER [Risk Ratio(RR)=0.56 ,95% CI 0.36–0.86; P = 0.008]. Conclusions SXBM combined with conventional treatment seemed to be beneficial for patients with IDA. However, the harmlessness of SXBM were not confirmed due to insufficient trials and low methodological quality.Follow-up clinical studies should be cautiously designed, and more research is needed.
DOI: 10.5519/qd.8h4oxdi8
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (560000 records)
DOI: 10.14278/rodare.1513
title: Data publication: Characterization of protein corona formation on nanoparticles via dynamic interfacial properties analysis: Bovine serum albumin - silica particle case study

description: Dynamic surface tension and elasticity values of BSA proteins and silica nanoparticles, in separated and also mixed solutions, measured via drop profile analysis tensiometry.
DOI: 10.14278/rodare.1512
title: Data publication: Characterization of protein corona formation on nanoparticles via dynamic interfacial properties analysis: Bovine serum albumin - silica particle case study

description: Dynamic surface tension and elasticity values of BSA proteins and silica nanoparticles, in separated and also mixed solutions, measured via drop profile analysis tensiometry.
DOI: 10.14278/rodare.1511
title: EZ publication: source code, profiling, analysis and simulation data

description: Data of the PIConGPU simulations as used in the publication: EZ: An Efficient, Charge Conserving Current Deposition Algorithm for Electromagnetic Particle-In-Cell Simulations Data overview: picongpu_source.zip: source code forked from the PIConGPU mainline version 0.7.0-dev used input set `share/picongpu/examples/PaperThermal` runs_charge_conservation.zip: output including hdf5 dumps to validate charge conservation property for the PaperThermal setup (warm plasma) runs_performance.zip: simulation timings output for Spock CPU, Spock GPU and Summit GPU runs runs_profiling.zip: profile data for Spock GPU and Summit GPU runs runs_singleParticleTest.zip: output including hdf5 dumps to validate charge conservation property for the single particle test analysis_scripts.zip: jupyter notebooks for setup and analysis of PaperThermal setup python script to plot charge conservation from hdf5 simulation output over time bash script for statistical analysis of performance runs
DOI: 10.14278/rodare.1510
title: EZ publication: source code, profiling, analysis and simulation data

description: Data of the PIConGPU simulations as used in the publication: EZ: An Efficient, Charge Conserving Current Deposition Algorithm for Electromagnetic Particle-In-Cell Simulations Data overview: picongpu_source.zip: source code forked from the PIConGPU mainline version 0.7.0-dev used input set `share/picongpu/examples/PaperThermal` runs_charge_conservation.zip: output including hdf5 dumps to validate charge conservation property for the PaperThermal setup (warm plasma) runs_performance.zip: simulation timings output for Spock CPU, Spock GPU and Summit GPU runs runs_profiling.zip: profile data for Spock GPU and Summit GPU runs runs_singleParticleTest.zip: output including hdf5 dumps to validate charge conservation property for the single particle test analysis_scripts.zip: jupyter notebooks for setup and analysis of PaperThermal setup python script to plot charge conservation from hdf5 simulation output over time bash script for statistical analysis of performance runs